4.3 Editorial Material

Tyrosine kinase inhibitors concentration monitoring in chronic myeloid leukemia

Journal

LEUKEMIA RESEARCH
Volume 34, Issue 6, Pages 698-699

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2009.12.009

Keywords

Chronic myeloid leukemia; Pharmacokinetics; Pharmacodynamics; Therapeutic drug monitoring; Prognostic factors; Imatinib; Nilotinib

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available